Cargando…

Exploring Response to Immunotherapy in Non-Small Cell Lung Cancer Using Delta-Radiomics

SIMPLE SUMMARY: The aim of the study is to identify radiomic features capable of predicting the response to immunotherapy. Delta-radiomics can foresees the comparison between subsequent CT scans and therefore allows to predict the changes that occurred during the treatment. In this study, the indivi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Barabino, Emanuele, Rossi, Giovanni, Pamparino, Silvia, Fiannacca, Martina, Caprioli, Simone, Fedeli, Alessandro, Zullo, Lodovica, Vagge, Stefano, Cittadini, Giuseppe, Genova, Carlo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8773717/ https://www.ncbi.nlm.nih.gov/pubmed/35053513 http://dx.doi.org/10.3390/cancers14020350

Ejemplares similares

Radiomic-based diagnostics in oncology: challenges toward clinical practice
por: Barabino, Emanuele, et al.
Publicado: (2021)

Immunotherapy in Adolescents and Young Adults: What Remains in Cancer Survivors?
por: Tanda, Enrica Teresa, et al.
Publicado: (2021)

High-Frequency Intraoral Ultrasound for Preoperative Assessment of Depth of Invasion for Early Tongue Squamous Cell Carcinoma: Radiological–Pathological Correlations
por: Caprioli, Simone, et al.
Publicado: (2022)

Delta-radiomics in cancer immunotherapy response prediction: A systematic review
por: Abbas, Engy, et al.
Publicado: (2023)

Metabolic Parameters as Biomarkers of Response to Immunotherapy and Prognosis in Non-Small Cell Lung Cancer (NSCLC): A Real World Experience
por: Monaco, Lavinia, et al.
Publicado: (2021)

Prognostic value of immunotherapy-induced organ inflammation assessed on (18)FDG PET in patients with metastatic non-small cell lung cancer
por: Humbert, Olivier, et al.
Publicado: (2022)

Precision Medicine for NSCLC in the Era of Immunotherapy: New Biomarkers to Select the Most Suitable Treatment or the Most Suitable Patient
por: Rossi, Giovanni, et al.
Publicado: (2020)

The Role of the Immune Metabolic Prognostic Index in Patients with Non-Small Cell Lung Cancer (NSCLC) in Radiological Progression during Treatment with Nivolumab
por: Bauckneht, Matteo, et al.
Publicado: (2021)

Potential application of cryobiopsy for histo-molecular characterization of mediastinal lymph nodes in patients with thoracic malignancies: a case presentation series and implications for future developments
por: Genova, Carlo, et al.
Publicado: (2022)

Combination of clinical, radiomic, and “delta” radiomic features in survival prediction of metastatic gastroesophageal adenocarcinoma
por: Krishna, Satheesh, et al.
Publicado: (2023)

Delta thermal radiomics: An application in dairy cow teats
por: Basran, P.S., et al.
Publicado: (2022)

Current Role of Delta Radiomics in Head and Neck Oncology
por: Marcu, David C., et al.
Publicado: (2023)

Novel Emerging Molecular Targets in Non-Small Cell Lung Cancer
por: Rebuzzi, Sara Elena, et al.
Publicado: (2021)

Radiomics to predict immunotherapy efficacy in advanced renal cell carcinoma: A retrospective study
por: Rossi, Ernesto, et al.
Publicado: (2023)

Role of radiomics in predicting immunotherapy response
por: Kothari, Gargi
Publicado: (2022)

An investigation of machine learning methods in delta-radiomics feature analysis
por: Chang, Yushi, et al.
Publicado: (2019)

Delta radiomics model for the prediction of progression-free survival time in advanced non-small-cell lung cancer patients after immunotherapy
por: Xie, Dong, et al.
Publicado: (2022)

Prognostic Role of Soluble and Extracellular Vesicle-Associated PD-L1, B7-H3 and B7-H4 in Non-Small Cell Lung Cancer Patients Treated with Immune Checkpoint Inhibitors
por: Genova, Carlo, et al.
Publicado: (2023)

Delta-Radiomics Predicts Response to First-Line Oxaliplatin-Based Chemotherapy in Colorectal Cancer Patients with Liver Metastases
por: Giannini, Valentina, et al.
Publicado: (2022)

Delta-radiomics features during radiotherapy improve the prediction of late xerostomia
por: van Dijk, Lisanne V., et al.
Publicado: (2019)

Non-V delta 2 gamma delta T lymphocytes as effectors of cancer immunotherapy
por: Fisher, Jonathan, et al.
Publicado: (2014)

Immune Checkpoint Blockade: A Strategy to Unleash the Potential of Natural Killer Cells in the Anti-Cancer Therapy
por: Grottoli, Melania, et al.
Publicado: (2022)

Local Recurrence of Soft Tissue Sarcoma: A Radiomic Analysis
por: Tagliafico, Alberto Stefano, et al.
Publicado: (2019)

MRI-based pre-Radiomics and delta-Radiomics models accurately predict the post-treatment response of rectal adenocarcinoma to neoadjuvant chemoradiotherapy
por: Wang, Likun, et al.
Publicado: (2023)

Radiomic biomarkers of tumor immune biology and immunotherapy response
por: Wang, Jarey H., et al.
Publicado: (2021)

Artificial intelligence and radiomics: fundamentals, applications, and challenges in immunotherapy
por: Dercle, Laurent, et al.
Publicado: (2022)

Radiomics and Delta-Radiomics Signatures to Predict Response and Survival in Patients with Non-Small-Cell Lung Cancer Treated with Immune Checkpoint Inhibitors
por: Cousin, François, et al.
Publicado: (2023)

PET Radiomics and Response to Immunotherapy in Lung Cancer: A Systematic Review of the Literature
por: Evangelista, Laura, et al.
Publicado: (2023)

Delta-radiomics features for the prediction of patient outcomes in non–small cell lung cancer
por: Fave, Xenia, et al.
Publicado: (2017)

Contemplating Dichotomous Nature of Gamma Delta T Cells for Immunotherapy
por: Bhat, Jaydeep, et al.
Publicado: (2022)

Predicting response to cancer immunotherapy using noninvasive radiomic biomarkers
por: Trebeschi, S, et al.
Publicado: (2019)

[(18)F]FDG PET Immunotherapy Radiomics Signature (iRADIOMICS) Predicts Response of Non-small-cell Lung Cancer Patients Treated with Pembrolizumab
por: Valentinuzzi, Damijan, et al.
Publicado: (2020)

Non-small-cell lung cancer: how to manage BRAF-mutated disease
por: Guaitoli, Giorgia, et al.
Publicado: (2023)

Refining Tumor Treatment in Sinonasal Cancer Using Delta Radiomics of Multi-Parametric MRI after the First Cycle of Induction Chemotherapy
por: Corino, Valentina D. A., et al.
Publicado: (2022)

Delta-radiomics signature predicts treatment outcomes after preoperative chemoradiotherapy and surgery in rectal cancer
por: Jeon, Seung Hyuck, et al.
Publicado: (2019)

How Does the Delta-Radiomics Better Differentiate Pre-Invasive GGNs From Invasive GGNs?
por: Ma, Yanqing, et al.
Publicado: (2020)

Quantitative ultrasound delta-radiomics during radiotherapy for monitoring treatment responses in head and neck malignancies
por: Tran, William T, et al.
Publicado: (2020)

A Delta-radiomics model for preoperative evaluation of Neoadjuvant chemotherapy response in high-grade osteosarcoma
por: Lin, Peng, et al.
Publicado: (2020)

The CT delta-radiomics based machine learning approach in evaluating multiple primary lung adenocarcinoma
por: Ma, Yanqing, et al.
Publicado: (2022)

Delta Radiomic Analysis of Mesorectum to Predict Treatment Response and Prognosis in Locally Advanced Rectal Cancer
por: Chiloiro, Giuditta, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_nkstkjt3kkjq68nas5t5562npo